Taloph Pharmaceuticals released its semi-annual performance report, with a net profit attributable to the parent company of 19.35 million yuan, a year-on-year decrease of 27.32%

According to the Zhitong Finance APP, Taloph disclosed its semi-annual report for 2025, showing that the company achieved revenue of 762 million yuan during the reporting period, a year-on-year decrease of 17.77%; net profit attributable to the parent company was 19.35 million yuan, a year-on-year decrease of 27.32%; net profit excluding non-recurring gains and losses was 15.19 million yuan, a year-on-year decrease of 40.64%; basic earnings per share were 0.0350 yuan